Glycan shielding and epitope reorganization drive sotrovimab resistance in SARS-CoV-2 Omicron variants
Archives of Biochemistry and Biophysics · 2026-08 · 782 · 110861
DOI: 10.1016/j.abb.2026.110861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-08. Verfasst von Ankit Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Computational Biology & Biomolecular Design, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanas…. Hauptthemen laut MEDLINE: Polysaccharides, Epitopes, Spike Glycoprotein, Coronavirus, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Indian Council of Medical Research, Science and Engineering Research Board.
Abstract (Originalsprache)
The rapid antigenic evolution of the SARS-CoV-2 spike protein has progressively eroded the efficacy of therapeutic monoclonal antibodies, including sotrovimab. Omicron BA.1 and BA.2 variants exhibit markedly reduced neutralization potency; however, the molecular and energetic mechanisms underlying this resistance, particularly the contribution of glycan-mediated epitope reorganization, remain insufficiently resolved. Here, we elucidate how BA.1 and BA.2 mutations reshape the structural dynamics, interfacial energetics, and glycan-mediated epitope masking in the sotrovimab-receptor-binding domain (RBD) complex. Extensive molecular dynamics simulations (1.5 μs all-atom; 15 μs coarse-grained) revealed that Omicron-specific mutations induce pronounced conformational plasticity within the RBD, accompanied by local secondary-structure destabilization and enhanced dynamic heterogeneity relative to the wild-type complex. These changes weaken sotrovimab-stabilizing hydrogen-bond networks and disrupt persistent interfacial contacts critical for sotrovimab recognition. Free-energy landscape analyses demonstrated a shift toward less favorable binding conformational states in both BA.1 and BA.2, consistent with reduced complex stability. Dynamic cross-correlation analysis further demonstrated progressive loss of coordinated long-range motions and fragmentation of the sotrovimab-RBD communication network, most prominently in BA.2. Binding free-energy decomposition further revealed substantial losses in overall affinity and pronounced redistribution of residue-level energetic contributions at the sotrovimab-RBD interface. Notably, mutation-induced reorientation and increased mobility of the conserved N343-linked glycan enhances steric shielding of the sotrovimab epitope and perturbs key glycan-mediated stabilizing interactions, amplifying sotrovimab-escape despite limited direct epitope mutation. Together, these results establish that sotrovimab resistance in Omicron BA.1 and BA.2 arises from a synergistic interplay of RBD conformational destabilization, weakened interfacial energetics, disrupted dynamic coupling, and glycan-mediated epitope shielding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Computational Biology & Biomolecular Design, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi, Uttar Pradesh, 221005, India.
- Molecular and Structural Biophysics Laboratory, Department of Zoology, North-Eastern Hill University, Shillong, India. Electronic address: timir.tripathi@gmail.com.
- Laboratory for Computational Biology & Biomolecular Design, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi, Uttar Pradesh, 221005, India. Electronic address: aditya.bce@iitbhu…
Förderung
- Indian Council of Medical Research
- Science and Engineering Research Board
Zitieren
APA
Kumar, A., Yadav, A. J., Tripathi, T., & Padhi, A. K. (2026). Glycan shielding and epitope reorganization drive sotrovimab resistance in SARS-CoV-2 Omicron variants. Archives of Biochemistry and Biophysics, 782, 110861. https://doi.org/10.1016/j.abb.2026.110861
Vancouver
Kumar A, Yadav AJ, Tripathi T, Padhi AK. Glycan shielding and epitope reorganization drive sotrovimab resistance in SARS-CoV-2 Omicron variants. Archives of Biochemistry and Biophysics. 2026;782:110861. doi:10.1016/j.abb.2026.110861
BibTeX
@article{Kumar2026,
author = {Kumar, Ankit and Yadav, Amar Jeet and Tripathi, Timir and Padhi, Aditya K},
title = {Glycan shielding and epitope reorganization drive sotrovimab resistance in SARS-CoV-2 Omicron variants},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {782},
pages = {110861},
doi = {10.1016/j.abb.2026.110861}
}
EUVIMED